Workflow
肠道微生物与胆汁酸协同阻断能量吸收机制
icon
Search documents
《自然·代谢》重磅:生酮饮食为何真能瘦?复旦科学家破解肠道微生物与胆汁酸协同阻断能量吸收新机制
GLP1减重宝典· 2025-08-03 09:07
Core Viewpoint - The article discusses the recent findings on the ketogenic diet, revealing its mechanisms for weight loss beyond traditional beliefs, particularly focusing on the role of specific bile acids and gut microbiota in reducing calorie absorption and promoting fat metabolism [6][7][15]. Group 1: Mechanisms of Ketogenic Diet - The ketogenic diet induces the production of ketone bodies, leading the body to utilize fat as an energy source, but recent studies show it also significantly increases energy expenditure [7]. - Research from Fudan University indicates that the ketogenic diet alters gut microbiota composition, reducing levels of bile salt hydrolase (BSH) and increasing levels of taurodeoxycholic acid (TDCA) and taurocholic acid (TUDCA), which inhibit calorie absorption [7][12]. - A clinical study involving over 400 participants confirmed that lower plasma levels of TDCA and TUDCA correlate with higher BMI and fasting blood glucose levels, suggesting these bile acids could be potential therapeutic targets for obesity [8][14]. Group 2: Experimental Findings - In a study with mice on a high-fat ketogenic diet (75.1% fat), significant weight loss and reduced fasting blood glucose were observed, alongside an increase in 22 metabolites, including six bile acids [11]. - The study found that TDCA and TUDCA significantly reduced body weight and improved glucose tolerance in normal diet mice, indicating their crucial role in the weight loss mechanism of the ketogenic diet [11][12]. - Analysis of gut microbiota revealed that specific strains, such as Lactobacillus murinus ASF361, significantly influence the levels of TDCA and TUDCA, thereby affecting weight and blood sugar levels [12][16]. Group 3: Clinical Implications - Participants in a 12-week ketogenic diet study lost an average of 5.27 kg, with significant increases in plasma TDCA and TUDCA levels, correlating with changes in BMI and fasting blood glucose [14]. - The findings support the potential of TDCA and TUDCA as therapeutic targets for obesity and related metabolic diseases, providing a new perspective on the mechanisms of weight loss through the ketogenic diet [15].